Published on 9 Nov 2022 on Zacks via Yahoo Finance
SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates
SurModics (SRDX) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 31.58%. A quarter ago, it was expected that this drug delivery technology company would post a loss of $0.39 per share when it actually produced a loss of $0.34, delivering a surprise of 12.82%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.